State CO
Clinical Trials in Colorado
Recruiting clinical trials with at least one study location in Colorado. Data updated daily from ClinicalTrials.gov.
Top Conditions in Colorado
NCT06570798 Phase 2
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune ...
Condition
Systemic Lupus Erythematosus
Enrollment
220 pts
Location
United States, Australia, Belgium
Sponsor
Amgen
NCT05050136 Phase 2
Recruiting
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixib...
Condition
Primary Biliary Cholangitis
Enrollment
260 pts
Location
United States, Argentina, Belgium
Sponsor
Mirum Pharmaceuticals, Inc.
NCT06717698 Phase 2
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130...
Condition
Chronic Kidney Disease
Enrollment
465 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT06008093 Phase 3
Recruiting
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combinati...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
280 pts
Location
United States
Sponsor
AstraZeneca
NCT03474029 Phase 2, Phase 3
Recruiting
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given D...
Condition
Latent Tuberculosis
Enrollment
3,400 pts
Location
United States, Australia, Canada
Sponsor
Centers for Disease Control an
NCT06660394 Phase 3
Recruiting
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults ...
Condition
Dravet Syndrome
Enrollment
160 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT06749457 Phase 1, Phase 2
Recruiting
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase...
Condition
Staphylococcus Aureus
Enrollment
231 pts
Location
United States
Sponsor
AstraZeneca
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06465953 Phase 3
Recruiting
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With ...
Condition
Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS)
Enrollment
48 pts
Location
United States, Australia, Brazil
Sponsor
Institut de Recherches Interna
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
NCT05862272 Phase 3
Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugoli...
Condition
Uterine Fibroids
Enrollment
1,000 pts
Location
United States
Sponsor
Sumitomo Pharma Switzerland Gm
NCT07015242 Phase 2
Recruiting
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as Fir...
Condition
Lymphoma
Enrollment
65 pts
Location
United States, France, Germany
Sponsor
Juno Therapeutics, Inc., a Bri
NCT02480283 N/A
Recruiting
Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Respo...
Condition
Cannabis Smoking
Enrollment
100 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT06833073 Phase 2
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Ca...
Condition
Urinary Bladder Neoplasms
Enrollment
308 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT04862221 Phase 2
Recruiting
TReatment for ImmUne Mediated PathopHysiology
Condition
Acute Liver Failure
Enrollment
163 pts
Location
United States
Sponsor
National Institute of Diabetes
NCT05238922 Phase 1
Recruiting
Study of INCB123667 in Subjects With Advanced Solid Tumors
Condition
Solid Tumors
Enrollment
604 pts
Location
United States, France, Italy
Sponsor
Incyte Corporation
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
NCT07028853 Phase 3
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrom...
Condition
Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT06914128 Phase 1, Phase 2
Recruiting
A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Part...
Condition
MTAP-deleted Solid Tumors
Enrollment
370 pts
Location
United States, Australia, Belgium
Sponsor
Bayer
NCT06933472 Phase 3
Recruiting
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosp...
Condition
Hyperphosphatemia
Enrollment
264 pts
Location
United States, China
Sponsor
Alebund Pharmaceuticals
NCT06152575 Phase 3
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in P...
Condition
Multiple Myeloma
Enrollment
492 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT07230834 Phase 1
Recruiting
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Condition
Geographic Atrophy (GA)
Enrollment
54 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05735236 N/A
Recruiting
Comparison of Methods in Post Operative Knee Arthroscopy Rehabilitation
Condition
ACL Tear
Enrollment
78 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT03877653 N/A
Recruiting
Freedom-1 Study for Chronic Knee Pain
Condition
Osteoarthritic Knee Pain
Enrollment
100 pts
Location
United States
Sponsor
Curonix LLC